Spots Global Cancer Trial Database for standard chemotherapy
Every month we try and update this database with for standard chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| TAilored Post-Surgical Therapy in Early Stage NSCLC | NCT00775385 | Carcinoma, Non-... | Standard Chemot... Customized Trea... | 18 Years - 70 Years | Intergroupe Francophone de Cancerologie Thoracique | |
| A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | NCT00642824 | Non-Squamous No... | Standard chemot... bevacizumab [Av... | 18 Years - | Hoffmann-La Roche | |
| Use of the MiCK Assay for Apoptosis in AML | NCT00286845 | Leukemia, Myelo... | Standard Chemot... | 18 Years - | Pierian Biosciences | |
| DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma | NCT04334759 | Mesothelioma Pleural Mesothe... Malignant Pleur... | Durvalumab Standard Chemot... Ipilimumab and ... | 18 Years - | PrECOG, LLC. | |
| An Open-label, Dose Escalation Multi-center Study in Patients With Advanced Cancer to Determine the Infusion Rate Effect of ASA 404 With Paclitaxel Plus Carboplatin Regimen or Docetaxel on the Pharmacokietics of Free and Total ASA404 | NCT01240642 | Metastatic Canc... Metastatic Canc... | ASA404 | 18 Years - | Novartis | |
| Patients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO Guidelines | NCT03622931 | Ovarian Cancer | Standard chemot... Romiplostim Placebos | 18 Years - | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | |
| A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma. | NCT00643565 | Sarcoma | Standard chemot... bevacizumab [Av... | 6 Months - 18 Years | Hoffmann-La Roche | |
| Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Mutation | NCT00893399 | Acute Myeloid L... | Gemtuzumab Ozog... standard chemot... | 18 Years - | University of Ulm | |
| Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer | NCT01394120 | Carcinoma, Panc... | Targeted Therap... Standard Chemot... | 18 Years - | Grupo Hospital de Madrid | |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2 | NCT04628026 | Acute Myeloid L... Myelodysplastic... | Venetoclax Placebo Standard chemot... Autologous stem... Allogeneic stem... | 18 Years - | University of Ulm | |
| Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer | NCT02483767 | Breast Cancer | goserelin standard chemot... | 18 Years - 45 Years | Peking Union Medical College Hospital | |
| Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer | NCT04263051 | Advanced Non-sm... | UCPVax + Nivolu... standard chemot... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL | NCT03319901 | Leukemia | Venetoclax Standard Chemot... | 18 Years - | Dana-Farber Cancer Institute | |
| A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2) | NCT00281697 | Metastatic Brea... | Bevacizumab Placebo Standard chemot... | 18 Years - | Genentech, Inc. | |
| Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma | NCT00691236 | Osteosarcoma | Zoledronic acid Standard chemot... | 18 Years - 65 Years | Tata Memorial Hospital | |
| Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT | NCT00718354 | Gastric Cancer Gastroesophagea... | Enoxaparin Standard Chemot... | 18 Years - 75 Years | Thrombosis Research Institute | |
| A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors | NCT01299701 | Advanced Solid ... | ASA404 | 18 Years - | Novartis | |
| Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer | NCT02483767 | Breast Cancer | goserelin standard chemot... | 18 Years - 45 Years | Peking Union Medical College Hospital | |
| Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine | NCT00293293 | Ovarian Cancer Peritoneal Prim... Fallopian Tube ... | healing touch massage therapy hypnosis Standard chemot... | - | Masonic Cancer Center, University of Minnesota | |
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study | NCT04065139 | Gastric Adenoca... Cancer Metastat... Chemotherapy Ef... | Pressurized int... Standard chemot... | 18 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
| Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma | NCT00691236 | Osteosarcoma | Zoledronic acid Standard chemot... | 18 Years - 65 Years | Tata Memorial Hospital | |
| A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer. | NCT00559754 | Breast Cancer | bevacizumab [Av... Docetaxel Standard chemot... | 18 Years - | Hoffmann-La Roche | |
| An Open-label, Dose Escalation Multi-center Study in Patients With Advanced Cancer to Determine the Infusion Rate Effect of ASA 404 With Paclitaxel Plus Carboplatin Regimen or Docetaxel on the Pharmacokietics of Free and Total ASA404 | NCT01240642 | Metastatic Canc... Metastatic Canc... | ASA404 | 18 Years - | Novartis | |
| A Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas | NCT03405454 | Ovarian Clear C... | durvalumab standard chemot... | 21 Years - 99 Years | National University Hospital, Singapore | |
| Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy | NCT06391775 | Malignant Solid... | GEN1055 Pembrolizumab Standard Chemot... | 18 Years - | Genmab | |
| A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer | NCT04031885 | Metastatic Brea... | Abemaciclib Fulvestrant Standard Chemot... | 18 Years - | Eli Lilly and Company | |
| Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL | NCT03319901 | Leukemia | Venetoclax Standard Chemot... | 18 Years - | Dana-Farber Cancer Institute | |
| A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer. | NCT00717405 | Breast Cancer | Standard chemot... bevacizumab [Av... trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer | NCT03949283 | Recurrent Ovari... Platinum-resist... | ChemoID Assay Standard Chemot... | 18 Years - | Cordgenics, LLC | |
| Trabectedin First Line Therapy In Unfit Sarcoma Study | NCT02066675 | Metastatic and ... Standard Chemot... | Trabectedin | 18 Years - 80 Years | Italian Sarcoma Group | |
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study | NCT04065139 | Gastric Adenoca... Cancer Metastat... Chemotherapy Ef... | Pressurized int... Standard chemot... | 18 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
| TAilored Post-Surgical Therapy in Early Stage NSCLC | NCT00775385 | Carcinoma, Non-... | Standard Chemot... Customized Trea... | 18 Years - 70 Years | Intergroupe Francophone de Cancerologie Thoracique | |
| A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors | NCT01299701 | Advanced Solid ... | ASA404 | 18 Years - | Novartis | |
| A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer. | NCT00717405 | Breast Cancer | Standard chemot... bevacizumab [Av... trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy | NCT06391775 | Malignant Solid... | GEN1055 Pembrolizumab Standard Chemot... | 18 Years - | Genmab | |
| Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine | NCT00293293 | Ovarian Cancer Peritoneal Prim... Fallopian Tube ... | healing touch massage therapy hypnosis Standard chemot... | - | Masonic Cancer Center, University of Minnesota | |
| A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer | NCT04031885 | Metastatic Brea... | Abemaciclib Fulvestrant Standard Chemot... | 18 Years - | Eli Lilly and Company | |
| PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study | NCT00911170 | Cancer Colon Cancer Colorectal Canc... Fever Locally Advance... Metastatic Colo... Neutropenia Rectal Cancer | Pegfilgrastim Placebo Bevacizumab Standard Chemot... | 18 Years - | Amgen | |
| A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors | NCT01299701 | Advanced Solid ... | ASA404 | 18 Years - | Novartis | |
| Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy | NCT03398291 | Pancreatic Canc... Liver Metastase... Surgery | Synchronous res... Standard chemot... | 18 Years - 75 Years | Fudan University | |
| Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer | NCT02483767 | Breast Cancer | goserelin standard chemot... | 18 Years - 45 Years | Peking Union Medical College Hospital | |
| Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT | NCT00718354 | Gastric Cancer Gastroesophagea... | Enoxaparin Standard Chemot... | 18 Years - 75 Years | Thrombosis Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
